diabetic macular edema
Novartis eye treatment for diabetics shows positive results in Phase III trial
May 4, 2021Manufacturing and Production DME, Novartis, diabetic macular edema, macular edema, pharma, pharma news
Novartis’ Beovu treatment for diabetic macular edema (DME) – an eye condition that can cause blindness – has shown positive …
NICE signs-off Roche’s Gazyvaro for leukaemia
June 2, 2015Sales and Marketing Allergan, Bayer, CLL, Carole Longson, Eylea, Gazyvaro, NICE, Ozurdex, Roche, diabetic macular edema, leukaemia
NICE has given positive final guidance backing the use of Roche’s Gazyvaro for people with chronic lymphocytic leukaemia (CLL). Earlier …
NICE to review Lucentis decision
August 17, 2011Sales and Marketing Lucentis, NICE, diabetic macular edema
NICE will allow an appeal against its decision not to recommend Novartis’s Lucentis for diabetic macular oedema. The appeal came …
Novartis’ Lucentis recommended for wider EU licence
October 25, 2010Sales and Marketing CHMP, Genentech, Lucentis, Novartis, diabetic macular edema, ranibizumab
Novartis’ Lucentis has been recommended for approval in Europe to treat people suffering from vison loss due to diabetes. The …
Latest content
FibroFind appoints Lee Borthwick as CEO
July 21, 2026
